Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TL-895 is an ATP-competitive, and highly selective irreversible inhibitor of Bruton’s Tyrosine Kinase(BTK). TL-895 showed good potency with an IC50 of 1.5 nM and a Ki of 11.9 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 157.00 | |
25 mg | In stock | $ 317.00 | |
50 mg | In stock | $ 493.00 | |
100 mg | In stock | $ 725.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 97.00 |
Description | TL-895 is an ATP-competitive, and highly selective irreversible inhibitor of Bruton’s Tyrosine Kinase(BTK). TL-895 showed good potency with an IC50 of 1.5 nM and a Ki of 11.9 nM. |
Targets&IC50 | BTK:11.9 nM(Ki), BTK:1.5 nM |
Molecular Weight | 447.5 |
Formula | C25H26FN5O2 |
CAS No. | 1415823-49-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (558.66 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TL-895 1415823-49-2 Angiogenesis Tyrosine Kinase/Adaptors BTK anti-viral Inhibitor Bruton tyrosine kinase TL895 Myelofibrosis Solid Tumor Carcinoma TL 895 Acute Myeloid Leukemia Btk Cancer Sars-CoV2 COVID-19 inhibit inhibitor